Literature DB >> 3021972

Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region.

G D Parks, G M Duke, A C Palmenberg.   

Abstract

All picornaviral peptides are derived by progressive posttranslational cleavage of a giant precursor polyprotein. Translation of encephalomyocarditis virus (EMC) RNA in rabbit reticulocyte extracts produces active viral peptides, including protease 3C, which is responsible for many cleavage reactions within the processing cascade. DNA plasmids containing 5' noncoding sequences of EMC linked to other portions of the viral genome were constructed and transcribed into RNA. Like virion RNA, the clone-derived transcripts directed efficient protein translation in vitro. The 5'-linked constructions may represent examples of a general method for cell-free expression of any cloned gene segment. One construction produced a self-cleaving P3 region precursor, which contained active 3C protease. A genetically engineered insertion within the 3C sequences eliminated endogenous self-cleavage activity without altering the ability of the P3 peptide to serve as substrate in bimolecular reactions with added 3C. Another plasmid encoding the L-VP0 portion of the capsid region was used to demonstrate that scission between the leader peptide (L) and capsid protein VP0 can be catalyzed by 3C. The enzyme responsible for this step was previously unidentified. A rapid purification scheme for isolation of 3C from EMC-infected HeLa cells is also presented.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021972      PMCID: PMC288903     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing.

Authors:  D S Shih; C T Shih; D Zimmern; R R Rueckert; P Kaesberg
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

2.  Protease required for processing picornaviral coat protein resides in the viral replicase gene.

Authors:  A C Palmenberg; M A Pallansch; R R Rueckert
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

3.  Poly(C) sequence is located near the 5'-end of encephalomyocarditis virus RNA.

Authors:  K M Chumakov; V I Agol
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

4.  Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme.

Authors:  H R Pelham
Journal:  Eur J Biochem       Date:  1978-04-17

5.  A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products.

Authors:  R J Jackson
Journal:  Virology       Date:  1986-02       Impact factor: 3.616

6.  Further evidence on the formation of poliovirus proteins.

Authors:  M F Jacobson; J Asso; D Baltimore
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

7.  Two-dimensional electrophoretic analysis of encephalomyocarditis viral proteins.

Authors:  M A Churchill; R J Radloff
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

8.  Proteolytic activity of the nonstructural polypeptide p22 of encephalomyocarditis virus.

Authors:  A E Gorbalenya; V I Agol
Journal:  Biochem Biophys Res Commun       Date:  1981-02-27       Impact factor: 3.575

9.  Protein-linked RNA of poliovirus is competent to form an initiation complex of translation in vitro.

Authors:  F Golini; B L Semler; A J Dorner; E Wimmer
Journal:  Nature       Date:  1980-10-16       Impact factor: 49.962

10.  Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA.

Authors:  D V Sangar; D N Black; D J Rowlands; T J Harris; F Brown
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more
  55 in total

1.  The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells.

Authors:  C Badshah; M A Calenoff; K Rundell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Expression of biologically active HIV glycoproteins using a T7 RNA polymerase-based eucaryotic vector system.

Authors:  T Wilk; H Mierswa; H G Kräusslich; J J Dunn; V Bosch
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

3.  Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors.

Authors:  G D Parks; A C Palmenberg
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  A genetic system for studying the activity of a proteolytic enzyme.

Authors:  B Dasmahapatra; B DiDomenico; S Dwyer; J Ma; I Sadowski; J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  Small nuclear inclusion protein encoded by a plant potyvirus genome is a protease.

Authors:  J C Carrington; W G Dougherty
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

Review 6.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

7.  Construction and characterization of two infectious molecular clones of encephalomyocarditis virus.

Authors:  R K Naviaux; S H Cohen; K M Vanden Brink; G W Jordan
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Aichi virus leader protein is involved in viral RNA replication and encapsidation.

Authors:  Jun Sasaki; Shigeo Nagashima; Koki Taniguchi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding.

Authors:  I Joung; J A Engler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.